Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference25 articles.
1. Vandegrift D, Datta A. Prescription drug expenditures in the united states: the effects of obesity, demographics, and new pharmaceutical products. South Econ J. 2006;73(2):515–29.
2. Vitry A, Nguyen T, Entwistle V, Roughead E. Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study. J Pharm Policy Pract. 2015;8:25.
3. Aggarwal A, Fojo T, Chamberlain C, Davis C, Sullivan R. Do patient access schemes for high-cost cancer drugs deliver value to society?-lessons from the NHS Cancer Drugs Fund. Ann Oncol. 2017;28(8):1738–50.
4. Smith IE. Efficacy and safety of Herceptin in women with metastatic breast cancer: results from pivotal clinical studies. Anticancer Drugs. 2001;12(Suppl 4):S3-10.
5. Eiermann W, International Herceptin Study G. Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: pivotal trial data. Ann Oncol. 2001;12:S57-62.